S&P 500   4,302.17 (+0.19%)
DOW   33,850.11 (+0.05%)
QQQ   354.25 (+0.31%)
AAPL   181.11 (+0.30%)
MSFT   326.05 (+0.24%)
META   265.59 (+0.38%)
GOOGL   122.80 (+0.54%)
AMZN   123.60 (-0.52%)
TSLA   247.29 (+5.29%)
NVDA   389.92 (+1.25%)
NIO   7.85 (+0.77%)
BABA   86.06 (-0.09%)
AMD   125.80 (+3.92%)
T   16.02 (-0.31%)
F   13.74 (+1.18%)
MU   64.80 (-0.80%)
CGC   0.67 (-3.36%)
GE   105.10 (-0.91%)
DIS   91.83 (-0.76%)
AMC   4.75 (+1.50%)
PFE   39.20 (+0.28%)
PYPL   62.98 (-1.96%)
NFLX   417.84 (+2.07%)
S&P 500   4,302.17 (+0.19%)
DOW   33,850.11 (+0.05%)
QQQ   354.25 (+0.31%)
AAPL   181.11 (+0.30%)
MSFT   326.05 (+0.24%)
META   265.59 (+0.38%)
GOOGL   122.80 (+0.54%)
AMZN   123.60 (-0.52%)
TSLA   247.29 (+5.29%)
NVDA   389.92 (+1.25%)
NIO   7.85 (+0.77%)
BABA   86.06 (-0.09%)
AMD   125.80 (+3.92%)
T   16.02 (-0.31%)
F   13.74 (+1.18%)
MU   64.80 (-0.80%)
CGC   0.67 (-3.36%)
GE   105.10 (-0.91%)
DIS   91.83 (-0.76%)
AMC   4.75 (+1.50%)
PFE   39.20 (+0.28%)
PYPL   62.98 (-1.96%)
NFLX   417.84 (+2.07%)
S&P 500   4,302.17 (+0.19%)
DOW   33,850.11 (+0.05%)
QQQ   354.25 (+0.31%)
AAPL   181.11 (+0.30%)
MSFT   326.05 (+0.24%)
META   265.59 (+0.38%)
GOOGL   122.80 (+0.54%)
AMZN   123.60 (-0.52%)
TSLA   247.29 (+5.29%)
NVDA   389.92 (+1.25%)
NIO   7.85 (+0.77%)
BABA   86.06 (-0.09%)
AMD   125.80 (+3.92%)
T   16.02 (-0.31%)
F   13.74 (+1.18%)
MU   64.80 (-0.80%)
CGC   0.67 (-3.36%)
GE   105.10 (-0.91%)
DIS   91.83 (-0.76%)
AMC   4.75 (+1.50%)
PFE   39.20 (+0.28%)
PYPL   62.98 (-1.96%)
NFLX   417.84 (+2.07%)
S&P 500   4,302.17 (+0.19%)
DOW   33,850.11 (+0.05%)
QQQ   354.25 (+0.31%)
AAPL   181.11 (+0.30%)
MSFT   326.05 (+0.24%)
META   265.59 (+0.38%)
GOOGL   122.80 (+0.54%)
AMZN   123.60 (-0.52%)
TSLA   247.29 (+5.29%)
NVDA   389.92 (+1.25%)
NIO   7.85 (+0.77%)
BABA   86.06 (-0.09%)
AMD   125.80 (+3.92%)
T   16.02 (-0.31%)
F   13.74 (+1.18%)
MU   64.80 (-0.80%)
CGC   0.67 (-3.36%)
GE   105.10 (-0.91%)
DIS   91.83 (-0.76%)
AMC   4.75 (+1.50%)
PFE   39.20 (+0.28%)
PYPL   62.98 (-1.96%)
NFLX   417.84 (+2.07%)
NASDAQ:ZYXI

Zynex (ZYXI) Stock Forecast, Price & News

$8.66
-0.22 (-2.48%)
(As of 11:32 AM ET)
Compare
Today's Range
$8.59
▼
$8.82
50-Day Range
$8.88
▼
$14.56
52-Week Range
$6.65
▼
$17.25
Volume
70,977 shs
Average Volume
320,228 shs
Market Capitalization
$317.39 million
P/E Ratio
19.24
Dividend Yield
N/A
Price Target
$19.63
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media

Zynex MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
128.2% Upside
$19.63 Price Target
Short Interest
Bearish
23.63% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
53.33%
From $0.45 to $0.69 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.05 out of 5 stars

Medical Sector

461st out of 986 stocks

Electromedical Equipment Industry

9th out of 22 stocks

See Top Rated MarketRank™ Stocks Here

ZYXI stock logo

About Zynex (NASDAQ:ZYXI) Stock

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.

Receive ZYXI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zynex and its competitors with MarketBeat's FREE daily newsletter.

ZYXI Stock News Headlines

June 2, 2023 | americanbankingnews.com
Analyzing Zynex (NASDAQ:ZYXI) and Precision Optics (NASDAQ:POCI)
May 29, 2023 | finance.yahoo.com
Those who invested in Zynex (NASDAQ:ZYXI) five years ago are up 214%
June 9, 2023 | Edge On The Street (Ad)
Graphite versus Lithium - What Investors Should Know
Over 18 million EVs will be cruising U.S roads by 2030. And every one million EVs manufactured will require 82,000 tons of the metal graphite for their batteries. That's a total of 1,476,000 tons of graphite! Graphite is actually the largest component of EV batteries - NOT lithium. Experts warn of a massive graphite shortfall, especially since North America currently has no operating graphite mines.
May 16, 2023 | americanbankingnews.com
Zynex (NASDAQ:ZYXI) versus Hyperfine (NASDAQ:HYPR) Financial Review
May 5, 2023 | finance.yahoo.com
After the recent decline, Zynex, Inc. (NASDAQ:ZYXI) CEO Thomas Sandgaard's holdings have lost 17% of their value
May 4, 2023 | finance.yahoo.com
Zynex Prices Upsized $52.5 Million Convertible Senior Notes Offering
May 4, 2023 | finance.yahoo.com
Zynex Announces Update Regarding Previously Announced Offerings
May 3, 2023 | finance.yahoo.com
Zynex Announces Proposed $50 Million Offering of Convertible Senior Notes
June 9, 2023 | PressReach (Ad)
This Stock's Worth Researching
Uncover the buzz behind this trending stock. Read the comprehensive report here.
May 3, 2023 | finance.yahoo.com
Zynex Announces Proposed Secondary Public Offering of Common Stock
May 3, 2023 | finance.yahoo.com
Zynex Named as a Winner of Colorado's Top Workplaces 2023 by The Denver Post
May 2, 2023 | americanbankingnews.com
Zynex (NASDAQ:ZYXI) Updates Q1 2023 Earnings Guidance
May 2, 2023 | americanbankingnews.com
Zynex (NASDAQ:ZYXI) Updates FY 2023 Earnings Guidance
May 2, 2023 | americanbankingnews.com
Brokers Set Expectations for Zynex, Inc.'s Q2 2023 Earnings (NASDAQ:ZYXI)
April 27, 2023 | finance.yahoo.com
Zynex Inc. (ZYXI) Beats Q1 Earnings and Revenue Estimates
April 27, 2023 | finance.yahoo.com
Zynex Announces 2023 First Quarter Earnings
April 19, 2023 | finance.yahoo.com
Zynex, Inc. to Announce First Quarter 2023 Financial Results
April 16, 2023 | americanbankingnews.com
Zynex (NASDAQ:ZYXI) Stock Rating Reaffirmed by HC Wainwright
April 13, 2023 | finance.yahoo.com
An Intrinsic Calculation For Zynex, Inc. (NASDAQ:ZYXI) Suggests It's 44% Undervalued
April 13, 2023 | americanbankingnews.com
Zynex (NASDAQ:ZYXI) Releases Q1 Earnings Guidance
April 13, 2023 | msn.com
HC Wainwright & Co. Reiterates Zynex (ZYXI) Buy Recommendation
April 12, 2023 | americanbankingnews.com
Zynex (NASDAQ:ZYXI) Issues FY23 Earnings Guidance
April 11, 2023 | finance.yahoo.com
Zynex Reports Preliminary First Quarter 2023 Results
April 6, 2023 | finance.yahoo.com
Zynex Earns Spot on Financial Times List of "The Americas' Fastest-Growing Companies 2023" for Second Consecutive Year
April 3, 2023 | benzinga.com
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Zynex, Inc. Investors to Inquire About Class Action Investigation - ZYXI
April 3, 2023 | benzinga.com
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zynex, Inc. - ZYXI
April 1, 2023 | marketwatch.com
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Zynex, Inc. Investors to Inquire About Class Action Investigation - ZYXI
See More Headlines

ZYXI Price History

ZYXI Company Calendar

Last Earnings
4/27/2023
Today
6/09/2023
Next Earnings (Estimated)
7/26/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ZYXI
CUSIP
N/A
CIK
846475
Web
www.zynex.com
Phone
(303) 703-4906
Fax
N/A
Employees
900
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$19.63
High Stock Price Forecast
$28.00
Low Stock Price Forecast
$12.50
Forecasted Upside/Downside
+121.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

EPS (Most Recent Fiscal Year)
$0.45
Trailing P/E Ratio
19.73
Forward P/E Ratio
19.73
P/E Growth
N/A
Net Income
$17.05 million
Net Margins
10.19%
Pretax Margin
12.89%
Return on Equity
26.02%
Return on Assets
14.91%

Debt

Debt-to-Equity Ratio
0.06
Current Ratio
3.09
Quick Ratio
2.42

Sales & Book Value

Annual Sales
$158.17 million
Price / Sales
2.06
Cash Flow
$0.53 per share
Price / Cash Flow
16.82
Book Value
$1.77 per share
Price / Book
5.02

Miscellaneous

Outstanding Shares
36,650,000
Free Float
19,588,000
Market Cap
$325.45 million
Optionable
Optionable
Beta
0.59

Key Executives

  • Mr. Thomas SandgaardMr. Thomas Sandgaard (Age 64)
    Founder, Pres, CEO & Chairman
    Comp: $1.14M
  • Mr. Daniel J. MoorheadMr. Daniel J. Moorhead (Age 51)
    Chief Financial Officer
    Comp: $423.77k
  • Ms. Anna Lucsok (Age 36)
    Chief Operating Officer
    Comp: $356.25k
  • Mr. Steve Fox
    VP Of Sales
  • Mr. Donald Gregg
    Pres of Zynex Monitoring Solutions
  • Mr. Neil Friery
    Pres & COO of Zynex Monitoring Solutions, Inc.

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













ZYXI Stock - Frequently Asked Questions

Should I buy or sell Zynex stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Zynex in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" ZYXI shares.
View ZYXI analyst ratings or view top-rated stocks.

What is Zynex's stock price forecast for 2023?

3 Wall Street research analysts have issued 12 month price targets for Zynex's shares. Their ZYXI share price forecasts range from $12.50 to $28.00. On average, they expect the company's stock price to reach $19.63 in the next twelve months. This suggests a possible upside of 121.0% from the stock's current price.
View analysts price targets for ZYXI or view top-rated stocks among Wall Street analysts.

How have ZYXI shares performed in 2023?

Zynex's stock was trading at $13.91 at the start of the year. Since then, ZYXI stock has decreased by 36.2% and is now trading at $8.88.
View the best growth stocks for 2023 here.

When is Zynex's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, July 26th 2023.
View our ZYXI earnings forecast.

How were Zynex's earnings last quarter?

Zynex, Inc. (NASDAQ:ZYXI) released its earnings results on Thursday, April, 27th. The company reported $0.04 earnings per share for the quarter, topping the consensus estimate of $0.01 by $0.03. The firm earned $42.17 million during the quarter, compared to analysts' expectations of $39.67 million. Zynex had a net margin of 10.19% and a trailing twelve-month return on equity of 26.02%.

What ETFs hold Zynex's stock?

ETFs with the largest weight of Zynex (NASDAQ:ZYXI) stock in their portfolio include Invesco S&P SmallCap 600 Pure Growth ETF (RZG), Hartford Multifactor Small Cap ETF (ROSC), First Trust Dow Jones Select Microcap Index Fund (FDM), Syntax Stratified SmallCap ETF (SSLY), Barrons 400 ETF (BFOR), Invesco S&P SmallCap Health Care ETF (PSCH) and Invesco S&P SmallCap Momentum ETF (XSMO) and

What guidance has Zynex issued on next quarter's earnings?

Zynex updated its first quarter 2023 earnings guidance on Tuesday, May, 2nd. The company provided earnings per share guidance of 0-$0.03 for the period, compared to the consensus estimate of $0.01. The company issued revenue guidance of $39.00 million-$41.00 million, compared to the consensus revenue estimate of $39.61 million.

What is Thomas Sandgaard's approval rating as Zynex's CEO?

81 employees have rated Zynex Chief Executive Officer Thomas Sandgaard on Glassdoor.com. Thomas Sandgaard has an approval rating of 87% among the company's employees.

What is Zynex's stock symbol?

Zynex trades on the NASDAQ under the ticker symbol "ZYXI."

Who are Zynex's major shareholders?

Zynex's stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (9.28%), State Street Corp (1.87%), Geode Capital Management LLC (1.19%), Anson Funds Management LP (0.00%), Anson Funds Management LP (0.00%) and Bank of New York Mellon Corp (0.74%). Insiders that own company stock include Anna Lucsok, Daniel J Moorhead and Thomas Sandgaard.
View institutional ownership trends.

How do I buy shares of Zynex?

Shares of ZYXI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Zynex's stock price today?

One share of ZYXI stock can currently be purchased for approximately $8.88.

How much money does Zynex make?

Zynex (NASDAQ:ZYXI) has a market capitalization of $325.45 million and generates $158.17 million in revenue each year. The company earns $17.05 million in net income (profit) each year or $0.45 on an earnings per share basis.

How many employees does Zynex have?

The company employs 900 workers across the globe.

How can I contact Zynex?

Zynex's mailing address is 9555 MAROON CIRCLE, ENGLEWOOD CO, 80112. The official website for the company is www.zynex.com. The company can be reached via phone at (303) 703-4906 or via email at info@zynex.com.

This page (NASDAQ:ZYXI) was last updated on 6/9/2023 by MarketBeat.com Staff

My Account -